| 发明名称 |
OSTEOCLAST INHIBITORS FOR KNEE CONDITIONS |
| 摘要 |
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, such as zoledronic acid, can be used to treat or alleviate pain or related conditions such as arthritis. |
| 申请公布号 |
US2017079998(A1) |
申请公布日期 |
2017.03.23 |
| 申请号 |
US201615371052 |
申请日期 |
2016.12.06 |
| 申请人 |
ANTECIP BIOVENTURES II LLC |
发明人 |
Tabuteau Herriot;Jones Graeme |
| 分类号 |
A61K31/675;A61K9/20;A61K9/00 |
主分类号 |
A61K31/675 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating pain associated with arthritis comprising orally administering zoledronic acid to a human being in need thereof, wherein the amount of zoledronic acid orally administered to the human being within a period of about one month is about 50 mg to about 100 mg. |
| 地址 |
New York NY US |
